Current causes of mesothelioma: how has the asbestos ban changed the perspective?
asbestos
mesothelioma
non-asbestos etiology
non-occupational exposure
occupational exposure
Journal
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
ISSN: 1804-7521
Titre abrégé: Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub
Pays: Czech Republic
ID NLM: 101140142
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
27
12
2022
accepted:
09
02
2023
medline:
15
6
2023
pubmed:
9
3
2023
entrez:
8
3
2023
Statut:
ppublish
Résumé
The association of mesothelioma, a lethal lung disease, with asbestos has led to an absolute ban on asbestos in at least 55 countries worldwide. The purpose of this paper is to review residual exposure to asbestos as well as other emerging causes of mesothelioma outside asbestos. The review provides detailed description of asbestos minerals, their geographical locations, mesothelioma in these areas, as well as contemporary possible sources of asbestos exposure. Second, we examine other emerging causes of mesothelioma including: ionizing radiation as the second most important risk factor after asbestos, particularly relevant to patients undergoing radiotherapy, third, carbon nanotubes which are under investigation and fourth, Simian virus 40. In the case of asbestos per se, the greatest risk is from occupational exposure during mining and subsequent processing. Of the non-occupational exposures, environmental exposure is most serious, followed by exposure from indoor asbestos minerals and secondary familial exposure. Overall, asbestos is still a major risk factor, but alternative causes should not be neglected, especially in young people, in women and those with a history of radiotherapy or living in high-risk locations.
Substances chimiques
Nanotubes, Carbon
0
Asbestos
1332-21-4
Minerals
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
99-108Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Neumann V, Löseke S, Nowak D, Herth FJ, Tannapfel A. Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health. Dtsch Arztebl Int 2013;110(18):319-26.
pubmed: 23720698
doi: 10.3238/arztebl.2013.0319
Tischoff I, Neid M, Neumann V, Tannapfel A. Pathohistological diagnosis and differential diagnosis. Recent Results Cancer Res 2011;189:57-78.
pubmed: 21479896
doi: 10.1007/978-3-642-10862-4_5
Beasley MB, Galateau-Salle F, Dacic S. Pleural mesothelioma classification update. Virchows Arch 2021;478(1):59-72.
pubmed: 33475835
doi: 10.1007/s00428-021-03031-7
Mesothelioma Fact Sheet. Cancer Today. 2020 [cited 2022 Sep 21]; Available from: https://gco.iarc.fr/today/fact-sheets-cancers.
Carbone M, Adusumilli PS, Alexander HR Jr, Baas P, Bardelli F, Bononi A, Bueno R, Felley-Bosco E, Galateau-Salle F, Jablons D, Mansfield AS, Minaai M, de Perrot M, Pesavento P, Rusch V, Severson DT, Taioli E, Tsao A, Woodard G, Yang H, Zauderer MG, Pass HI. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy [published correction appears in CA Cancer J Clin 2020 Jul;70(4):313-314]. CA Cancer J Clin 2019;69(5):402-29.
pubmed: 31283845
doi: 10.3322/caac.21572
Tischoff I, Tannapfel A. Mesotheliom [Mesothelioma]. Pathologe 2017;38(6):547-60.
pubmed: 28986649
doi: 10.1007/s00292-017-0364-z
Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, Roggli VL. Malignant Mesothelioma and Its Non-Asbestos Causes. Arch Pathol Lab Med 2018;142(6):753-60.
pubmed: 29480760
doi: 10.5858/arpa.2017-0365-RA
Gandhi M, Nair S. New vistas in malignant mesothelioma: MicroRNA architecture and NRF2/MAPK signal transduction. Life Sci 2020;257:118123.
pubmed: 32710945
doi: 10.1016/j.lfs.2020.118123
Opitz I. Management of malignant pleural mesothelioma-The European experience. J Thorac Dis 2014;6 Suppl 2(Suppl 2):S238-S52.
Case BW, Abraham JL, Meeker G, Pooley FD, Pinkerton KE. Applying definitions of "asbestos" to environmental and "low-dose" exposure levels and health effects, particularly malignant mesothelioma. J Toxicol Environ Health B Crit Rev 2011;14(1-4):3-39.
pubmed: 21534084
doi: 10.1080/10937404.2011.556045
ISO 10312:2019(en): Ambient air - Determination of asbestos fibres - Direct transfer transmission electron microscopy method. ISO Online Browsing Platform. 2019 [cited 2022 Sep 21]; Available from: https://www.iso.org/obp/ui/#iso:std:iso:10312:ed-2:v1:en.
Asbestos: Geology, Mineralogy, Mining, and Uses. Asbestos Statistics and Information. 2022 [cited 2022 Sep 21]; Available from: https://pubs.usgs.gov/of/2002/of02-149/.
Solbes E, Harper RW. Biological responses to asbestos inhalation and pathogenesis of asbestos-related benign and malignant disease. J Investig Med 2018;66(4):721-27.
pubmed: 29306869
doi: 10.1136/jim-2017-000628
Furuya S, Chimed-Ochir O, Takahashi K, David A, Takala J. Global Asbestos Disaster. Int J Environ Res Public Health 2018;15(5):1000.
pubmed: 29772681
doi: 10.3390/ijerph15051000
Stayner L, Welch LS, Lemen R. The worldwide pandemic of asbestos-related diseases. Annu Rev Public Health 2013;34:205-16.
pubmed: 23297667
doi: 10.1146/annurev-publhealth-031811-124704
Pira E, Donato F, Maida L, Discalzi G. Exposure to asbestos: past, present and future. J Thorac Dis 2018;10(Suppl 2):S237-S45.
pubmed: 29507791
doi: 10.21037/jtd.2017.10.126
ASBESTOS: Mineral Commodity Summaries. Asbestos Statistics and Information. 2022 [cited 2022 Sep 21]; Available from: https://pubs.usgs.gov/periodicals/mcs2021/mcs2021-asbestos.pdf; Asbestos (usgs.gov).
Current Asbestos Bans. International Ban Asbestos Secretariat. 2022 [cited 2022 Sep 21]; Available from: http://ibasecretariat.org/alpha_ban_list.php.
Brook MS, Black PM, Salmond J, Dirks KN, Berry TA, Steinhorn G. Erionite in Auckland bedrock and malignant mesothelioma: an emerging public and occupational health hazard? N Z Med J 2020;133(1518):73-78.
Goldberg M, Luce D. The health impact of nonoccupational exposure to asbestos: what do we know? Eur J Cancer Prev 2009;18(6):489-503.
pubmed: 19617842
doi: 10.1097/CEJ.0b013e32832f9bee
Patel JP, Brook MS. Erionite asbestiform fibres and health risk in Aotearoa/New Zealand: A research note. N Z Geog 2021;77(2),123-9.
doi: 10.1111/nzg.12291
Carbone M, Baris YI, Bertino P, Brass B, Comertpay S, Dogan AU, Gaudino G, Jube S, Kanodia S, Partridge CR, Pass HI, Rivera ZS, Steele I, Tuncer M, Way S, Yang H, Miller A. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proc Natl Acad Sci U S A 2011;108(33):13618-23.
pubmed: 21788493
doi: 10.1073/pnas.1105887108
Arsenic, metals, fibres, and dusts. In IARC Monographs: Volume 100 C A review of human carcinogens. International Agency for Research on Cancer. 2009 [cited 2022 Sep 21]; (pp. 219 - 315). Available from: https://monographs.iarc.who.int/wp-content/uploads/2018/06/mono100C.pdf
Some Nanomaterials and Some Fibres: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 111. International Agency for Research on Cancer. 2014 [cited 2022 Sep 21]; Available from: https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Some-Nanomaterials-And-Some-Fibres-2017
List of classifications by cancer sites with sufficient or limited evidence in humans: IARC Monographs Volumes 1-132a. IARC MONOGRAPHS ON THE IDENTIFICATION OF CARCINOGENIC HAZARDS TO HUMANS. 2022 [cited 2022 Sep 21]; Available from: https://monographs.iarc.who.int/wp-content/uploads/2019/07/Classifications_by_cancer_site.pdf
Emri SA. The Cappadocia mesothelioma epidemic: its influence in Turkey and abroad. Ann Transl Med 2017;5(11):239.
pubmed: 28706907
doi: 10.21037/atm.2017.04.06
Filetti V, Vitale E, Broggi G, Hagnäs MP, Candido S, Spina A, Lombardo C. Update of in vitro, in vivo and ex vivo fluoro-edenite effects on malignant mesothelioma: A systematic review (Review). Biomed Rep 2020;13(6):60.
pubmed: 33149905
doi: 10.3892/br.2020.1367
Emri S, Demir A, Dogan M, Akay H, Bozkurt B, Carbone M, Baris I. Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicol Lett 2002;127(1-3):251-7.
pubmed: 12052665
doi: 10.1016/S0378-4274(01)00507-0
McDonald JC, McDonald AD. The epidemiology of mesothelioma in historical context. Eur Respir J 1996;9(9):1932-42.
pubmed: 8880114
doi: 10.1183/09031936.96.09091932
Matanoski GM, Tonascia JA, Correa-Villaseñor A, Yates KC, Fink N, Elliott E, Sanders B, Lantry D. Cancer risks and low-level radiation in U.S. shipyard workers. J Radiat Res 2008;49(1):83-91.
pubmed: 17690532
doi: 10.1269/jrr.06082
Goodman JE, Nascarella MA, Valberg PA. Ionizing radiation: a risk factor for mesothelioma. Cancer Causes Control 2009;20(8):1237-54.
pubmed: 19444627
doi: 10.1007/s10552-009-9357-4
Visci G, Rizzello E, Zunarelli C, Violante FS, Boffetta P. Relationship between exposure to ionizing radiation and mesothelioma risk: A systematic review of the scientific literature and meta-analysis. Cancer Med 2022;11(3):778-89.
pubmed: 35029060
doi: 10.1002/cam4.4436
Mizuki M, Yukishige K, Abe Y, Tsuda T. A case of malignant pleural mesothelioma following exposure to atomic radiation in Nagasaki. Respirology 1997;2(3):201-05.
pubmed: 9400682
doi: 10.1111/j.1440-1843.1997.tb00079.x
Farioli A, Violante FS, Mattioli S, Curti S, Kriebel D. Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort analysis of SEER database. Cancer Causes Control 2013;24(8):1535-45.
pubmed: 23702885
doi: 10.1007/s10552-013-0230-0
Chang ET, Lau EC, Mowat FS, Teta MJ. Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma. Cancer Causes Control 2017;28(9):971-79.
pubmed: 28755241
doi: 10.1007/s10552-017-0929-4
De Bruin ML, Burgers JA, Baas P, van 't Veer MB, Noordijk EM, Louwman MW, Zijlstra JM, van den Berg H, Aleman BM, van Leeuwen FE. Malignant mesothelioma after radiation treatment for Hodgkin lymphoma. Blood 2009;113(16):3679-81.
pubmed: 19234144
doi: 10.1182/blood-2008-10-184705
Farioli A, Ottone M, Morganti AG, Compagnone G, Romani F, Cammelli S, Mattioli S, Violante FS. Radiation-induced mesothelioma among long-term solid cancer survivors: a longitudinal analysis of SEER database. Cancer Med 2016;5(5):950-59.
pubmed: 26860323
doi: 10.1002/cam4.656
Metz-Flamant C, Guseva Canu I, Laurier D. Malignant pleural mesothelioma risk among nuclear workers: a review. J Radiol Prot 2011;31(1):9-23.
pubmed: 21346295
doi: 10.1088/0952-4746/31/1/R01
Mumma MT, Sirko JL, Boice JD Jr, Blot WJ. Mesothelioma mortality within two radiation monitored occupational cohorts. Int J Radiat Biol 2022;98(4):786-94.
pubmed: 31290725
doi: 10.1080/09553002.2019.1642540
Gibb H, Fulcher K, Nagarajan S, McCord S, Fallahian NA, Hoffman HJ, Haver C, Tolmachev S. Analyses of radiation and mesothelioma in the US Transuranium and Uranium Registries. Am J Public Health 2013;103(4):710-16.
pubmed: 23409888
doi: 10.2105/AJPH.2012.300928
Dong J, Ma Q. Integration of inflammation, fibrosis, and cancer induced by carbon nanotubes. Nanotoxicology 2019;13(9):1244-74.
pubmed: 31537143
doi: 10.1080/17435390.2019.1651920
Kane AB, Hurt RH, Gao H. The asbestos-carbon nanotube analogy: An update. Toxicol Appl Pharmacol 2018;361:68-80.
pubmed: 29960000
doi: 10.1016/j.taap.2018.06.027
Kim JS, Song KS, Lee JK, Choi YC, Bang IS, Kang CS, Yu IJ. Toxicogenomic comparison of multi-wall carbon nanotubes (MWCNTs) and asbestos. Arch Toxicol 2012;86(4):553-62.
pubmed: 22076105
doi: 10.1007/s00204-011-0770-6
Rittinghausen S, Hackbarth A, Creutzenberg O, Ernst H, Heinrich U, Leonhardt A, Schaudien D. The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats. Part Fibre Toxicol 2014;11:59.
pubmed: 25410479
doi: 10.1186/s12989-014-0059-z
Takagi A, Hirose A, Futakuchi M, Tsuda H, Kanno J. Dose-dependent mesothelioma induction by intraperitoneal administration of multi-wall carbon nanotubes in p53 heterozygous mice. Cancer Sci 2012;103(8):1440-4.
doi: 10.1111/j.1349-7006.2012.02340.x
Fukushima S, Kasai T, Umeda Y, Ohnishi M, Sasaki T, Matsumoto M. Carcinogenicity of multi-walled carbon nanotubes: challenging issue on hazard assessment. J Occup Health 2018;60(1):10-30.
pubmed: 29046510
doi: 10.1539/joh.17-0102-RA
Orsi M, Al Hatem C, Leinardi R, Huaux F. Carbon nanotubes under scrutiny: Their toxicity and utility in mesothelioma research. Appl Sci 2020;10.13:4513.
doi: 10.3390/app10134513
Grosse Y, Loomis D, Guyton KZ, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Scoccianti C, Mattock H, Straif K. Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes. Lancet Oncol 2014;15(13):1427-28.
pubmed: 25499275
doi: 10.1016/S1470-2045(14)71109-X
Kuempel ED, Jaurand MC, Møller P, Morimoto Y, Kobayashi N, Pinkerton KE, Sargent LM, Vermeulen RC, Fubini B, Kane AB. Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans. Crit Rev Toxicol 2017;47(1):1-58.
pubmed: 27537422
doi: 10.1080/10408444.2016.1206061
Price MJ, Darnton AJ, McElvenny DM, Hodgson JT. Simian virus 40 and mesothelioma in Great Britain. Occup Med (Lond) 2007;57(8):564-68.
pubmed: 17675661
doi: 10.1093/occmed/kqm079
Vilchez RA, Kozinetz CA, Arrington AS, Madden CR, Butel JS. Simian virus 40 in human cancers. Am J Med 2003;114(8):675-84.
pubmed: 12798456
doi: 10.1016/S0002-9343(03)00087-1
Procopio A, Strizzi L, Vianale G, Betta P, Puntoni R, Fontana V, Tassi G, Gareri F, Mutti L. Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma. Genes Chromosomes Cancer 2000;29(2):173-79.
doi: 10.1002/1098-2264(2000)9999:9999<::AID-GCC1019>3.0.CO;2-B
Carbone M, Gazdar A, Butel JS. SV40 and human mesothelioma. Transl Lung Cancer Res 2020;9(Suppl 1):S47-S59.
pubmed: 32206570
doi: 10.21037/tlcr.2020.02.03
Agents Classified by the IARC Monographs, Volumes 1-123. IARC Monographs on the identification of carcinogenic hazards to humans. 2018 [cited 2022 Sep 23]; Available from: https://monographs.iarc.who.int/wp-content/uploads/2018/09/ClassificationsAlphaOrder.pdf
Ji J, Sundquist J, Sundquist K. Incidence and familial risk of pleural mesothelioma in Sweden: a national cohort study. Eur Respir J 2016;48(3):873-79.
pubmed: 27174879
doi: 10.1183/13993003.00091-2016
Tunesi S, Ferrante D, Mirabelli D, Andorno S, Betti M, Fiorito G, Guarrera S, Casalone E, Neri M, Ugolini D, Bonassi S, Matullo G, Dianzani I, Magnani C. Gene-asbestos interaction in malignant pleural mesothelioma susceptibility. Carcinogenesis 2015;36(10):1129-35.
pubmed: 26139392
doi: 10.1093/carcin/bgv097
Betti M, Aspesi A, Ferrante D, Sculco M, Righi L, Mirabelli D, Napoli F, Rondón-Lagos M, Casalone E, Vignolo Lutati F, Ogliara P, Bironzo P, Gironi CL, Savoia P, Maffè A, Ungari S, Grosso F, Libener R, Boldorini R, Valiante M, Pasini B, Matullo G, Scagliotti G, Magnani C, Dianzani I. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes. Genes Chromosomes Cancer 2018;57(11):573-83.
pubmed: 30338612
doi: 10.1002/gcc.22670
Franko A, Kotnik N, Goricar K, Kovac V, Dodic-Fikfak M, Dolzan V. The Influence of Genetic Variability on the Risk of Developing Malignant Mesothelioma. Radiol Oncol 2018;52(1):105-11.
pubmed: 29520212
doi: 10.2478/raon-2018-0004
Napolitano A, Pellegrini L, Dey A, Larson D, Tanji M, Flores EG, Kendrick B, Lapid D, Powers A, Kanodia S, Pastorino S, Pass HI, Dixit V, Yang H, Carbone M. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Oncogene 2016;35(15):1996-2002.
pubmed: 26119930
doi: 10.1038/onc.2015.243
Piber P, Vavpetic N, Goricar K, Dolzan V, Kovac V, Franko A. The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesothelioma. Radiol Oncol 2020;54(4):429-36.
pubmed: 33085641
doi: 10.2478/raon-2020-0057
Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, Patel JD, Rose B, Zhang SR, Weatherly M, Nelakuditi V, Knight Johnson A, Helgeson M, Fischer D, Desai A, Sulai N, Ritterhouse L, Røe OD, Turaga KK, Huo D, Segal J, Kadri S, Li Z, Kindler HL, Churpek JE. Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma. J Clin Oncol 2018;36(28):2863-71.
pubmed: 30113886
doi: 10.1200/JCO.2018.78.5204
Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960;17(4):260-71.
pubmed: 13782506
doi: 10.1136/oem.17.4.260
Murray R. Asbestos: a chronology of its origins and health effects. Br J Ind Med 1990;47(6):361-65.
pubmed: 2088320
doi: 10.1136/oem.47.6.361
Lilienfeld DE. The silence: the asbestos industry and early occupational cancer research-a case study. Am J Public Health 1991;81(6):791-800.
pubmed: 2029056
doi: 10.2105/AJPH.81.6.791
Hashim D, Boffetta P. Occupational and environmental exposures and cancers in developing countries. Ann Glob Health 2014;80(5):393-411.
pubmed: 25512155
doi: 10.1016/j.aogh.2014.10.002
Occupational Asbestos Exposure. The Mesothelioma Center. 2022 [cited 2022 Sep 22]; Available from: https://www.asbestos.com/occupations/.
Reid A, de Klerk NH, Magnani C, Ferrante D, Berry G, Musk AW, Merler E. Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis. Thorax 2014;69(9):843-50.
pubmed: 24842786
doi: 10.1136/thoraxjnl-2013-204161
Ferrante D, Mirabelli D, Silvestri S, Azzolina D, Giovannini A, Tribaudino P, Magnani C. Mortality and mesothelioma incidence among chrysotile asbestos miners in Balangero, Italy: A cohort study. Am J Ind Med 2020;63(2):135-45.
pubmed: 31821579
doi: 10.1002/ajim.23071
Wilczyńska U, Szymczak W, Szeszenia-Dabrowska N. Mortality from malignant neoplasms among workers of an asbestos processing plant in Poland: results of prolonged observation. Int J Occup Med Environ Health 2005;18(4):313-26.
pubmed: 16617847
Świątkowska B, Szeszenia-Dąbrowska N. Mesothelioma continues to increase even 40 years after exposure - Evidence from long-term epidemiological observation. Lung Cancer 2017;108:121-25.
pubmed: 28625623
doi: 10.1016/j.lungcan.2017.03.012
Williams PR, Phelka AD, Paustenbach DJ. A review of historical exposures to asbestos among skilled craftsmen (1940-2006). J Toxicol Environ Health B Crit Rev 2007;10(5):319-77.
pubmed: 17687724
doi: 10.1080/10937400601034191
Koskinen K, Pukkala E, Martikainen R, Reijula K, Karjalainen A. Different measures of asbestos exposure in estimating risk of lung cancer and mesothelioma among construction workers. J Occup Environ Med 2002;44(12):1190-96.
pubmed: 12500463
doi: 10.1097/00043764-200212000-00015
Cohen HJ, Van Orden DR. Asbestos exposures of mechanics performing clutch service on motor vehicles. J Occup Environ Hyg 2008;5(3):148-56.
pubmed: 18188736
doi: 10.1080/15459620701853227
Neitzel RL, Sayler SK, Demond AH, d'Arcy H, Garabrant DH, Franzblau A. Measurement of asbestos emissions associated with demolition of abandoned residential dwellings. Sci Total Environ 2020;722:137891.
pubmed: 32208261
doi: 10.1016/j.scitotenv.2020.137891
Harding AH, Darnton AJ. Asbestosis and mesothelioma among British asbestos workers (1971-2005). Am J Ind Med 2010;53(11):1070-80.
pubmed: 20957726
doi: 10.1002/ajim.20844
Rake C, Gilham C, Hatch J, Darnton A, Hodgson J, Peto J. Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer 2009;100(7):1175-83.
pubmed: 19259084
doi: 10.1038/sj.bjc.6604879
Muscat JE, Wynder EL. Cigarette smoking, asbestos exposure, and malignant mesothelioma. Cancer Res 1991;51(9):2263-67.
Corfiati M, Scarselli A, Binazzi A, Di Marzio D, Verardo M, Mirabelli D, Gennaro V, Mensi C, Schallemberg G, Merler E, Negro C, Romanelli A, Chellini E, Silvestri S, Cocchioni M, Pascucci C, Stracci F, Romeo E, Trafficante L, Angelillo I, Menegozzo S, Musti M, Cavone D, Cauzillo G, Tallarigo F, Tumino R, Melis M, Iavicoli S, Marinaccio A. Epidemiological patterns of asbestos exposure and spatial clusters of incident cases of malignant mesothelioma from the Italian national registry. BMC Cancer 2015;15:286.
pubmed: 25885893
doi: 10.1186/s12885-015-1301-2
Mensi C, Macchione M, Termine L, Canti Z, Rivolta G, Riboldi L, Chiappino G. Esposizioni professionali nel settore tessile non-amianto in Lombardia: i dati del Registro Regionale [Asbestos exposure in the non-asbestos textile industry: the experience of the Lombardy Mesothelioma Registry]. Epidemiol Prev 2007;31(4 Suppl 1):27-30.
Yu IJ, Choi JK, Kang SK, Chang HK, Chung YH, Han JH, Song KS, Lee YM, Chung HK. Potential source of asbestos in non-asbestos textile manufacturing company. Environ Int 2002;28(1-2):35-39.
pubmed: 12046952
doi: 10.1016/S0160-4120(02)00002-8
Barbieri PG, Somigliana A, Lombardi S, Girelli R, Rocco A, Pezzotti C, Silvestri S. Riciclaggio di sacchi di juta, patologie asbesto-correlate ed esposizione ad amianto in agricoltura [Recycle of jute bags; asbestos in agriculture, exposure and pathology]. G Ital Med Lav Ergon 2008;30(4):329-33.
Bianchi C, Bianchi T, Ramani L. Mesotelioma maligno della pleura nella donna [Malignant mesothelioma of the pleura among women]. Med Lav 2004;95(5):376-80.
pubmed: 15595200
Emri S, Demir A, Dogan M, Akay H, Bozkurt B, Carbone M, Baris I. Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicol Lett 2002;127(1-3):251-57.
pubmed: 12052665
doi: 10.1016/S0378-4274(01)00507-0
Pan XL, Day HW, Wang W, Beckett LA, Schenker MB. Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med 2005;172(8):1019-25.
pubmed: 15976368
doi: 10.1164/rccm.200412-1731OC
Sakellariou K, Malamou-Mitsi V, Haritou A, Koumpaniou C, Stachouli C, Dimoliatis ID, Constantopoulos SH. Malignant pleural mesothelioma from nonoccupational asbestos exposure in Metsovo (north-west Greece): slow end of an epidemic? Eur Respir J 1996;9(6):1206-10.
pubmed: 8804939
doi: 10.1183/09031936.96.09061206
Bloise A, Catalano M, Critelli T, Apollaro C, Miriello D. Naturally occurring asbestos: potential for human exposure, san Severino Lucano (Basilicata, southern Italy). Environmental Earth Sciences 2017;76.19:1-13.
doi: 10.1007/s12665-017-6995-9
Hendrickx M. Naturally occurring asbestos in eastern Australia: a review of geological occurrence, disturbance and mesothelioma risk. Env Geol 2009;57.4:909-26.
doi: 10.1007/s00254-008-1370-5
Goldberg M, Luce D. The health impact of nonoccupational exposure to asbestos: what do we know? Eur J Cancer Prev 2009;18(6):489-503.
pubmed: 19617842
doi: 10.1097/CEJ.0b013e32832f9bee
Noonan CW. Environmental asbestos exposure and risk of mesothelioma. Ann Transl Med 2017;5(11):234.
pubmed: 28706902
doi: 10.21037/atm.2017.03.74
Bourdès V, Boffetta P, Pisani P. Environmental exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Eur J Epidemiol 2000;16(5):411-17.
pubmed: 10997827
doi: 10.1023/A:1007691003600
Pan XL, Day HW, Wang W, Beckett LA, Schenker MB. Residential proximity to naturally occurring asbestos and mesothelioma risk in California. Am J Respir Crit Care Med 2005;172(8):1019-25.
pubmed: 15976368
doi: 10.1164/rccm.200412-1731OC
Airoldi C, Magnani C, Lazzarato F, Mirabelli D, Tunesi S, Ferrante D. Environmental asbestos exposure and clustering of malignant mesothelioma in community: a spatial analysis in a population-based case-control study. Environ Health 2021;20(1):103.
pubmed: 34526026
doi: 10.1186/s12940-021-00790-3
Marinaccio A, Binazzi A, Bonafede M, Corfiati M, Di Marzio D, Scarselli A, Verardo M, Mirabelli D, Gennaro V, Mensi C, Schallemberg G, Merler E, Negro C, Romanelli A, Chellini E, Silvestri S, Cocchioni M, Pascucci C, Stracci F, Ascoli V, Trafficante L, Angelillo I, Musti M, Cavone D, Cauzillo G, Tallarigo F, Tumino R, Melis M. Malignant mesothelioma due to non-occupational asbestos exposure from the Italian national surveillance system (ReNaM): epidemiology and public health issues. Occup Environ Med 2015;72(9):648-55.
pubmed: 26045315
doi: 10.1136/oemed-2014-102297
Goswami E, Craven V, Dahlstrom DL, Alexander D, Mowat F. Domestic asbestos exposure: a review of epidemiologic and exposure data. Int J Environ Res Public Health 2013;10(11):5629-70.
pubmed: 24185840
doi: 10.3390/ijerph10115629
Sahmel J, Barlow CA, Gaffney S, Avens HJ, Madl AK, Henshaw J, Unice K, Galbraith D, DeRose G, Lee RJ, Van Orden D, Sanchez M, Zock M, Paustenbach DJ. Airborne asbestos take-home exposures during handling of chrysotile-contaminated clothing following simulated full shift workplace exposures. J Expo Sci Environ Epidemiol 2016;26(1):48-62.
pubmed: 25921082
doi: 10.1038/jes.2015.15
Magnani C, Agudo A, González CA, Andrion A, Calleja A, Chellini E, Dalmasso P, Escolar A, Hernandez S, Ivaldi C, Mirabelli D, Ramirez J, Turuguet D, Usel M, Terracini B. Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos. Br J Cancer 2000;83(1):104-11.
pubmed: 10883677
doi: 10.1054/bjoc.2000.1161
Xu R, Barg FK, Emmett EA, Wiebe DJ, Hwang WT. Association between mesothelioma and non-occupational asbestos exposure: systematic review and meta-analysis. Environ Health 2018;17(1):90.
pubmed: 30567579
doi: 10.1186/s12940-018-0431-9
Corn M, Crump K, Farrar DB, Lee RJ, McFee DR. Airborne concentrations of asbestos in 71 school buildings. Regul Toxicol Pharmacol 1991;13(1):99-114.
pubmed: 2024049
doi: 10.1016/0273-2300(91)90044-V
Marsh GM, Riordan AS, Keeton KA, Benson SM. Non-occupational exposure to asbestos and risk of pleural mesothelioma: review and meta-analysis. Occup Environ Med 2017;74(11):838-46.
pubmed: 28935666
doi: 10.1136/oemed-2017-104383